The role of tocilizumab as a rescue therapy in patients with glucocorticoid resistant giant cell arteritis

被引：0
|
作者：
Stretton, Brandon [1 ]
Tan, Yiran [1 ]
Hassall, Mark [1 ]
Simon, Sumu [1 ]
机构：
[1] Royal Adelaide Hosp, Dept Ophthalmol, Adelaide, SA, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2022年 / 49卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：917 / 917
页数：1
相关论文
共 50 条
  • [21] Vision loss in patients with giant cell arteritis treated with tocilizumab
    Jennifer Amsler
    Iveta Kysela
    Christoph Tappeiner
    Luca Seitz
    Lisa Christ
    Godehard Scholz
    Odile Stalder
    Florian Kollert
    Stephan Reichenbach
    Peter M. Villiger
    Arthritis Research & Therapy, 23
  • [22] AN AUDIT OF GLUCOCORTICOID PRESCRIPTION IN PATIENTS WITH GIANT CELL ARTERITIS
    Ariff, H. H.
    Awisat, A.
    Arnold, J.
    Al Ani, H.
    O'neill, L.
    Rodriguez, M. P.
    Luqmani, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1265 - 1266
  • [23] AN AUDIT OF GLUCOCORTICOID PRESCRIPTION IN PATIENTS WITH GIANT CELL ARTERITIS
    Ariff, Hairul Hadi
    Awisat, Abid
    Arnold, Jack
    Al Ani, Hudaifa
    Neill, Lorraine O'
    Rodriguez, Mar Pujades
    Luqmani, Raashid
    RHEUMATOLOGY, 2020, 59
  • [24] The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis
    Jogimahanti, Arjun V.
    Kini, Ashwini T.
    Irwin, Lauren E.
    Lee, Andrew G.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2021, 41 (03) : 342 - 350
  • [25] Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis
    Adler, Sabine
    Reichenbach, Stephan
    Gloor, Andrea
    Yerly, Daniel
    Cullmann, Jennifer L.
    Villiger, Peter M.
    RHEUMATOLOGY, 2019, 58 (09) : 1639 - 1643
  • [26] Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes
    Proven, A
    Gabriel, SE
    Orces, C
    O'Fallon, WM
    Hunder, GG
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (05): : 703 - 708
  • [27] Optimization of Tocilizumab Therapy in Giant Cell Arteritis: A Multicenter Real Life Study of 134 Patients
    Calderon-Goercke, Monica
    Loricera, Javier
    Prieto-Pena, Diana
    Castaneda, Santos
    Aldasoro Caceres, Vicente
    Villa, Ignacio
    Humbria, Alicia
    Moriano, Clara
    Romero-Yuste, Susana
    Narvaez, Javier
    Gomez-Arango, Catalina
    Perez Pampin, Eva
    Melero, Rafael
    Becerra-Fernandez, Elena
    Revenga, Marcelino
    Alvarez-Rivas, Noelia
    Galisteo, Carles
    Sivera, Francisca
    Olive-Marques, Alejandro
    Alvarez del Buergo, Maria
    Marena-Rojas, Luisa
    Fernandez-Lopez, Carlos
    Navarro, Francisco
    Raya, E.
    Galindez-Agirregoikoa, Eva
    Arca, Beatriz
    Solans-Laque, Roser
    Conesa, Arantxa
    Hidalgo, Cristina
    Vazquez, Carlos
    Andres Roman-Ivorra, Jose
    Lluch, Pau
    Manrique, Sara
    Vela, P.
    de Miguel, Eugenio
    Torres-Martin, Carmen
    Carlos Nieto, Juan
    Ordas-Calvo, Carmen
    Salgado-Perez, Eva
    Luna-Gomez, Cristina
    Javier Toyos-Saenz De Miera, F.
    Fernandez-Llanio, Nagore
    Garcia, Antonio
    Larena, Carmen
    Varela-Garcia, Maria
    Aurrecoechea, Elena
    Ortiz-Sanjuan, Francisco
    Luis Hernandez, Jose
    Angel Gonzalez-Gay, Miguel
    Blanco, Ricardo
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [28] Tocilizumab for giant cell arteritis: what is optimal?
    Kaymakci, M.
    Warrington, K. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (04) : 777 - 779
  • [29] Efficacy of tocilizumab in refractory giant cell arteritis
    Vinit, Julien
    Bielefeld, Philip
    Muller, Geraldine
    Besancenot, Jean-Francois
    JOINT BONE SPINE, 2012, 79 (03) : 317 - 318
  • [30] Trial of Tocilizumab in Giant-Cell Arteritis
    Akiyama, Mitsuhiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (15): : 1493 - 1494
12345